Phase 4
After a medicine is licensed and approved by the Food and Drug Administration, researchers use phase 4 clinical trials to track the treatment's safety, seeking more information about its risks, benefits, and optimal use. (NIH)
After a medicine is licensed and approved by the Food and Drug Administration, researchers use phase 4 clinical trials to track the treatment's safety, seeking more information about its risks, benefits, and optimal use. (NIH)
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
